Lytix Biopharma AS (LYTIX) — Norway Stock Chart & News | StockAdder

(LYTIX)

Lytix Biopharma AS

Live chart and latest LYTIX stock news.

Market ETF → ENOR Norway

Chart powered byTradingView— professional charts for every trader.Try it free →

LYTIX News

Lytix Biopharma Overhauls Board and Renews Capital Mandate at AGM

Apr 14, 2026 Finansavisen

Lytix Biopharma AS: Minutes from Annual General Meeting

Apr 14, 2026 TipRanks

Lytix Biopharma Grants Share Options to Board Member Under Incentive Plan

Apr 9, 2026 Barchart

Intratumoral Cancer Therapies Market: Expanding Revenue Landscape to 2034 – DelveInsight | Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharma, Checkmate Pharma, Replimune

Apr 10, 2026 Investing.com

Earnings call transcript: Lytix Biopharma Q3 2025 reveals strategic progress

Nov 18, 2025 Finansavisen

Lytix Biopharma AS: Minutes from Annual General Meeting

Apr 14, 2026 TipRanks

Lytix Biopharma Appoints New COO to Drive Next Growth Phase

Apr 7, 2026 Investing.com

Lytix Biopharma Q1 2025 slides: Clinical progress and strengthened financial position

May 15, 2025 Finansavisen

Lytix Biopharma AS - Publication of Prospectus regarding Subsequent Offering and commencement of Subscription Period

Jan 27, 2026 PR Newswire

Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight

Dec 4, 2025 OncLive

VP-315 Induces Reductions in Tumor Size in Basal Cell Carcinoma

Aug 14, 2024 Finansavisen

Lytix Biopharma AS: Notice of Annual General Meeting on 14 April 2026

Mar 25, 2026 The Business Journals

Verrica arranges $50M financing to pay off debt, pursue 'billion-dollar market opportunities'

Nov 24, 2025 GlobeNewswire

Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market

Apr 1, 2025 Biostock

News round-up Monday, October 16